Currently, there are 359.36M common shares owned by the public and among those 354.46M shares have been available to trade.
The company’s stock has a 5-day price change of -2.60% and 30.28% over the past three months. FNB shares are trading 6.59% year to date (YTD), with the 12-month market performance up to 3.92% higher. It has a 12-month low price of $10.88 and touched a high of $17.70 over the same period. FNB has an average intraday trading volume of 2.99 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 3.19%, 7.10%, and 5.47% respectively.
Institutional ownership of F.N.B. Corp (NYSE: FNB) shares accounts for 81.04% of the company’s 359.36M shares outstanding.
It has a market capitalization of $5.53B and a beta (3y monthly) value of 0.96. The stock’s trailing 12-month PE ratio is 12.12, while the earnings-per-share (ttm) stands at $1.27. The company has a PEG of 1.24 and the debt-to-equity ratio at 0.74. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.92% over the week and 2.11% over the month.
Analysts forecast that F.N.B. Corp (FNB) will achieve an EPS of 0.34 for the current quarter, 0.36 for the next quarter and 1.67 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.32 while analysts give the company a high EPS estimate of 0.32. Comparatively, EPS for the current quarter was 0.34 a year ago. Earnings per share for the fiscal year are expected to increase by 1.92%, and 18.27% over the next financial year. EPS should grow at an annualized rate of 9.80% over the next five years, compared to 1.72% over the past 5-year period.
Looking at the support for the FNB, a number of firms have released research notes about the stock. Truist stated their Buy rating for the stock in a research note on May 13, 2025, with the firm’s price target at $16.50. Keefe Bruyette coverage for the F.N.B. Corp (FNB) stock in a research note released on April 21, 2025 offered a Outperform rating with a price target of $16.50. BofA Securities was of a view on January 11, 2024 that the stock is Buy, while Stephens gave the stock Overweight rating on April 04, 2023, issuing a price target of $15. Keefe Bruyette on their part issued Mkt Perform rating on December 13, 2022.
